A prospective randomized study comparing tacrolimus and sirolimus versus cyclosporine and methotrexate as gvhd prophylaxis in allogeneic hematopoietic stem cell transplantation

被引：0
|
作者：
Torlen, J. [1 ,2 ]
Ringden, O. [1 ]
Garming-Legert, K. [3 ]
Ljungman, P. [1 ,4 ,5 ]
Winiarski, J. [6 ]
Remes, K. [7 ,8 ]
Itala-Remes, M. [7 ]
Remberger, M. [1 ,2 ]
Mattsson, J. [1 ,2 ]
机构：
[1] Karolinska Inst, Karolinska Univ Hosp, Ctr Allogene Stem Cell Transplantat, Stockholm, Sweden
[2] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden
[3] Karolinska Inst, Karolinska Univ Hosp, Dept Dent Med, Div Oral & Maxillofacial Surg, Stockholm, Sweden
[4] Karolinska Univ Hosp, Dept Hematol, Stockholm, Sweden
[5] Karolinska Inst, Karolinska Univ Hosp, Div Hematol, Dept Med, Stockholm, Sweden
[6] Karolinska Univ Hosp, Astrid Lindgren Childrens Hosp, Stockholm, Sweden
[7] Turku Univ Hosp, Dept Internal Med, FIN-20520 Turku, Finland
[8] Turku Univ, Turku, Finland
来源：
BONE MARROW TRANSPLANTATION | 2016年 / 51卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
O032
引用
下载
收藏
页码：S21 / S21
页数：1
相关论文
共 50 条
  • [21] Sirolimus, tacrolimus and low-dose methotrexate as GVHD prophylaxis is safe and associated with promising results in patients receiving reduced-toxicity allogeneic hematopoietic cell transplantation
    Avila, A. M.
    Barba, P.
    Cho, C.
    Devlin, S.
    Ceberio, I.
    Ponce, D.
    Maloy, M.
    Perales, M. A.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S167 - S167
  • [22] The Addition of Sirolimus to GVHD Prophylaxis After Allogeneic Hematopoietic Stem Cell Transplantation: A Meta-Analysis of Efficacy and Safety
    Chen, Xiaoli
    Sun, Hengrui
    Cassady, Kaniel
    Yang, Shijie
    Chen, Ting
    Wang, Li
    Yan, Hongju
    Zhang, Xi
    Feng, Yimei
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [23] Tacrolimus plus sirolimus with or without ATG as GVHD prophylaxis in HLA-mismatched unrelated donor allogeneic stem cell transplantation
    Kharfan-Dabaja, M. A.
    Parody, R.
    Perkins, J.
    Lopez-Godino, O.
    Lopez-Corral, L.
    Vazquez, L.
    Caballero, D.
    Falantes, J.
    Shapiro, J.
    Orti, G.
    Barba, P.
    Valcarcel, D.
    Esquirol, A.
    Martino, R.
    Pinana, J. L.
    Solano, C.
    Tsalatsanis, A.
    Pidala, J.
    Anasetti, C.
    Perez-Simon, J. A.
    BONE MARROW TRANSPLANTATION, 2017, 52 (03) : 438 - 444
  • [24] The Outcome of the Combination of Tacrolimus, Sirolimus, and ATG for GvHD Prophylaxis on Allogeneic Stem Cell Transplantation From Matched Unrelated Donors.
    Homsi, Yaser
    Alwan, Dareen
    Kiel, Patrick
    Rosenbeck, Lindsay
    Shivani, Srivastava
    Schwartz, Jennifer E.
    Nelson, Robert P., Jr.
    Abonour, Rafat
    Robertson, Michael
    Farag, Sherif
    BLOOD, 2010, 116 (21) : 969 - 969
  • [25] Tacrolimus plus sirolimus with or without ATG as GVHD prophylaxis in HLA-mismatched unrelated donor allogeneic stem cell transplantation
    M A Kharfan-Dabaja
    R Parody
    J Perkins
    O Lopez-Godino
    L Lopez-Corral
    L Vazquez
    D Caballero
    J Falantes
    J Shapiro
    G Ortí
    P Barba
    D Valcárcel
    A Esquirol
    R Martino
    J L Piñana
    C Solano
    A Tsalatsanis
    J Pidala
    C Anasetti
    J A Perez-Simón
    Bone Marrow Transplantation, 2017, 52 : 438 - 444
  • [26] Sirolimus combined with tacrolimus as graft-versus-host disease prophylaxis after allogeneic stem cell transplantation
    Mattsson, J.
    Svenberg, P.
    Gustafsson, B.
    Remberger, M.
    Ringden, O.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S234 - S234
  • [27] Comparison of tacrolimus and cyclosporine combined with methotrexate for graft-versus-host disease prophylaxis after allogeneic hematopoietic cell transplantation: a meta-analysis
    Chen, M.
    Lin, X.
    Huang, B.
    Zhang, Y.
    Zheng, Y.
    Deng, M.
    He, X.
    TRANSPLANTATION, 2019, 103 (08) : 151 - 151
  • [28] A phase II pilot study of tacrolimus/sirolimus GVHD prophylaxis for sibling donor hematopoietic stem cell transplantation using 3 conditioning regimens
    Rodriguez, Roberto
    Nakamura, Ryotaro
    Palmer, Joycelynne M.
    Parker, Pablo
    Shayani, Sepideh
    Nademanee, Auyaporn
    Snyder, David
    Pullarkat, Vinod
    Kogut, Neil
    Rosenthal, Joseph
    Smith, Eileen
    Karanes, Chatchada
    O'Donnell, Margaret
    Krishnan, Amrita Y.
    Senitzer, David
    Forman, Stephen J.
    BLOOD, 2010, 115 (05) : 1098 - 1105
  • [29] SIROLIMUS COMPARED TO METHOTREXATE BASED IMMUNOSUPPRESSION FOR GRAFT-VERSUS-HOST DISEASE (GVHD) PROPHYLAXIS IN ALLOGENEIC STEM CELL TRANSPLANTATION: A SINGLE INSTITUTION EXPERIENCE
    Kiel, P. J.
    Rosenbeck, L. L.
    Kalsekar, I.
    Baute, J.
    Abdelqader, S.
    Sullivan, C. K.
    Schwartz, J.
    Srivastava, S.
    Abonour, R.
    Robertson, M. J.
    Nelson, R. P.
    Fausel, C. A.
    Farag, S. S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S319 - S319
  • [30] Comparison of Tacrolimus and Cyclosporine combined with methotrexate for graft-versus-host disease prophylaxis after allogeneic hematopoietic cell transplantation: a meta-analysis
    Chen, M.
    Lin, X.
    Zhang, Z.
    He, X.
    TRANSPLANTATION, 2018, 102 : 215 - 215
12345